presented at hawi'i health policy forum - october 2005 what accounts for the rise in health...
TRANSCRIPT
Presented at Hawi'i Health Policy Forum - October 2005
What Accounts for the Rise in Health Care Spending and What to Do About It: Future Directions for Health Care Reform
Kenneth E. Thorpe, Ph.D.Robert W. Woodruff Professor and Chair
Department of Health Policy and ManagementRollins School of Public Health
Emory [email protected]
Presented at Hawi'i Health Policy Forum - October 2005
Overview
• Crafting effective health reform solutions requires a clear understanding of what accounts for the growth in spending
• Key “facts” from the US context1. 80% of total health care spending linked to
chronically ill patients2. Chronically ill receive approximately 50% of all
clinically recommended medical care3. Rise in “treated disease prevalence” accounts
for nearly two-thirds of the growth in health care spending
4. Rise in obesity prevalence in US accounted for 27% of the growth in health spending over the past 20 years.
Presented at Hawi'i Health Policy Forum - October 2005
More than 80% of Health Care Spending on Behalf of People with Chronic Conditions
1 Chronic
Condition,
21%
2 Chronic
Conditions,
18%
3 Chronic
Conditions,
16%
4 Chronic
Conditions,
12%
5+ Chronic
Conditions,
16%
O Chronic
Conditions,
17%
Presented at Hawi'i Health Policy Forum - October 2005
Distribution of Medical Care Spending by Number of Chronic Health Care Conditions, 2001
Number of Chronic Health Care Conditions
Percent of Total Health Care Spending
Percent of Population
0
1
2
3
4
5
Total All Chronic Care
17%
21%
18%
16%
12%
16%
83%
55%
24%
11%
5%
4%
1%
45%
Presented at Hawi'i Health Policy Forum - October 2005
Issue: Level vs. Change in Spending
Level: US Spends 50% more per capita than European countries
• Traced to higher clinical and administrative expenses, fragmented purchases, and ultimately higher prices
Change: Growth in spending in US has risen faster that 19 of 23 OECD countries between 1980 and 2003.
Presented at Hawi'i Health Policy Forum - October 2005
Why Does Real Per Capita Health Spending Rise Over Time?
1. Rise in Treated Disease Prevalence
2. Rise in Spending Per Treated Case
3. Both
Presented at Hawi'i Health Policy Forum - October 2005
Rise in Treated Disease Prevalence Linked to the Rise in Obesity Key Single Largest Driver of Health Care Spending Over Time- Accounts for 62% of Rise in Per Capita Spending
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Heart Disease Diabetes Cancer Depression High Blood Pressure Back Problems
Presented at Hawi'i Health Policy Forum - October 2005
Percent of Privately Insured Population Treated, By Medical Condition, 1987-2002
Medical Condition 1987 % 2002 %Mental Disorders
Hyperlipidemia
Hypertension
Diabetes
Pulmonary Conditions (OPD, Asthma)
Lupus/Other Related
Arthritis
Back Problems
Upper GI
Kidney Problems
4.7%
1.4%
9.3%
2.4%
9.3%
4.2%
4.6%
4.6%
2.6%
0.7%
11.0%
7.4%
12.0%
4.0%
17.7%
6.5%
7.6%
8.1%
7.0%
1.3%
Presented at Hawi'i Health Policy Forum - October 2005
What Accounts for The Rise in Treated Disease Prevalence?
1. Rise in Population Disease Prevalence – fueled by obesity and other risk factors
2. Changes in threshold for treating asymptomatic patients (hypertension, hyperlipidemia, the metabolic syndrome)
3. Innovation (SSRI, statins, medical devices)
Presented at Hawi'i Health Policy Forum - October 2005
Changes in Obesity Prevalence, 1978-2000
15.1%
31.0%26.6%
31.1%
49.6%
38.9%
0%
10%
20%
30%
40%
50%
60%
Total BlackFemales
HispanicFemales
1978
2000
Presented at Hawi'i Health Policy Forum - October 2005
Changes in Obesity Prevalence, 1978-2000
6.5%
15.8%
0%
2%
4%
6%
8%
10%
12%
14%
16%
18%
Children
1978
2000
Presented at Hawi'i Health Policy Forum - October 2005
Rise in Treated Disease Prevalence Linked to the Rise in Obesity Key Single Largest Driver of Health Care Spending Over Time
% Change in Spending Over Time, 1987-2002
Rise in Obesity Prevalence Holding Technology Constant
= 11%
Rise in Additional Cost Of Treating Obese vs. Normal Weighted Patients
= 16%
TOTAL = 27%
Presented at Hawi'i Health Policy Forum - October 2005
Implications for Reform1. Universal Coverage will need assurance that we
have the ability to control spending- need policy options address both level and growth.
2. Policy options for reform need to attack the key drivers of cost—rising disease prevalence. Reforms need to result in better value care provided to all patients, but in particular to chronically ill patients.
3. Change how plans are paid and compete. Drive competition around specific chronic diseases that accounts for the most spending, most of the growth in spending. Ability to effectively treat multiple chronic conditions.
Presented at Hawi'i Health Policy Forum - October 2005
Implications for Reform
4. Develop captitated payment based on• Annual cost of providing all clinically
recommended care for patients with single or multiple chronic illnesses (starting to occur in the market today—Medicare already has the methodology for risk adjusting payments.
5. Compete on value• Best clinical outcomes at lowest cost• No co-pays or deductibles for clinically
recommended services.• Assures access to state-of-the-art care by most
vulnerable patients.
Presented at Hawi'i Health Policy Forum - October 2005
Implications – Slowing the Growth in Spending
1. Key Issues: Slow rise in treated disease prevalence through,
• Slowing the rise in obesity prevalence
2. Policy Tools• School Based Interventions• New and effective health promotion, wellness,
disease prevention programs available for all adults
• Financial incentives to participate
Presented at Hawi'i Health Policy Forum - October 2005
Summary
• Changes outlined above requires fundamental restructuring of US and most European health care systems
• Structure competition among health plans, provide groups around key chronic conditions
• Develop national strategy for addressing rise in treated disease prevalence
• Devote resources to developing effective health promotion, wellness programs for use in schools, and the worksite.